The Director of Post-Market Surveillance and Clinical Evaluation leads the global strategy, governance, and compliance of Post Market Surveillance and Clinical Evaluation activities, ensuring accuracy, regulatory alignment, and continuous improvement across markets through standardized systems and processes. Leads and inspire global teams, fostering a culture of collaboration, accountability, and high performance to ensure consistent delivery of centralized capabilities across all markets.
#LI-AK1
Software Powered by iCIMS
www.icims.com